Basic Search  |  Summaries  |  Advanced SearchPenalty: £75,573
Year: 2020
Date: 4 March, 2020
Offence Group: competition-related offences
Offence Type: price-fixing or anti-competitive practices
Violation Description: King and Praze were jointly and severally liable (as companies with common ownership) for a £75,573 fine in settlement of a decision by the CMA that the companies had illegally shared commercially sensitive information with other suppliers of the drug nortriptyline to keep prices up. Alissa Healthcare Research also paid a fine in settlement of the decision and Lexon appealed the decision.
Action Type: agency action
Settlement Type: Settlement with the CMA
Case Number: 50507
Agency: Competition and Markets Authority
Source of Data: (click here)